Simone Cagnacci
University of Genoa
12 Papers
18 Citations
Simone Cagnacci is an academic researcher from University of Genoa. The author has contributed to research in topics: Ceftazidime & Ciprofloxacin. The author has an hindex of 3, co-authored 12 publications.
Chat about Author
Papers
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak
Simone Cagnacci,L. Gualco,S. Roveta,Stefania Mannelli,Luisa Borgianni,Jean Denis Docquier,Ferdinando Dodi,Monica Centanaro,Eugenio A. Debbia,Anna Marchese,Gian Maria Rossolini +10 more
TL;DR: This is the first report on the emergence of an MDR strain of K. pneumoniae producing the VIM-1 MBL, causing an outbreak of bloodstream infections in an Italian hospital.
100
Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC)
TL;DR: Endox exhibited an effect on microrganisms which is reminiscent with that occuring in electroporation, but with a mode of action that saved materials and time.
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation.
TL;DR: Findings indicate that both the radiosensitivity of C. albicans and its response to the synergistic effects of γ-radiations and KTC are filamentation-dependent pharmacological processes.
Utilizzo del sistema Uro-Quick per l’identificazione rapida di batteri produttori di ß-lattamasi a spettro esteso (ESBL)
Simone Cagnacci,Fabrizio Cavallini,Elisabetta Maioli,S. Roveta,Clara Cassanelli,Anna Marchese,Eugenio A. Debbia +6 more
- 30 Jun 2005
TL;DR: Uro-Quick represents a useful technology to detect ESBL-producing strains especially those that required further confirmatory tests for their identification, and the period of time needed to achieve the results might be an advantage over the usual methodologies.
Antimicrobial susceptibility survey of pathogens isolated from selected patients in Northern Italy
Elisabetta Maioli,Italo DeMandina,Simone Cagnacci,Clara Cassanelli,Fabrizio Cavallini,Laura Gualco,S. Roveta,Anna Marchese,Eugenio A. Debbia +8 more
- 31 Mar 2005
TL;DR: The Clinical Microbiology Laboratory of the University of Genoa participated, during the year 2003, in an international antimicrobial surveillance program and found fluoroquinolone resistance was very rare among pneumococci except for ciprofloxacin.